RTX to take $3 billion charge on Pratt & Whitney engine problem

RTX to take  billion charge on Pratt & Whitney engine problem


Model of a Pratt & Whitney GTF engine is displayed at the 54th International Paris Air Show at Le Bourget Airport near Paris, France, June 20, 2023. 

Benoit Tessier | Reuters

RTX said Monday that an engine manufacturing flaw forcing accelerated inspections will hit its pretax results this quarter by $3 billion, sending shares lower in premarket trading.

The problem stems from flaws with powder metal used to make some of the popular Pratt & Whitney GTF engines. That issue is forcing inspections on hundreds of engines ahead of schedule, depriving airlines of some aircraft during a travel rebound in the pandemic’s wake.

RTX said that about 600 to 700 engines beyond the company’s early forecast will have to be removed for shop visits through 2026.

The engines power many of the popular Airbus A320neo planes and others.

RTX, formerly known as Raytheon Technologies, reaffirmed its adjusted earnings estimates of $4.95 to $5.05 a share for 2023. But it said it expects a $1.5 billion hit to cash flow in 2025, bringing that estimate to $7.5 billion from an earlier estimate of $9 billion.

The company said it expects the issue to cost up to $7 billion. Pratt & Whitney has a 51% share in the GTF PW1000 engine program and the cost will be shared.



Source

Forgotten no more: Generation X is driving beauty sales
Business

Forgotten no more: Generation X is driving beauty sales

Ryan Mckeever | E+ | Getty Images Move over, Sephora kids. While younger generations have been buying beauty products in droves, data shows that a different generation holds more spending power: Generation X. Often dubbed the “forgotten generation,” Gen X spans those born between 1965 and 1980, according to Pew Research Center. Sandwiched between baby […]

Read More
FDA fast-tracks psychedelic drug research following Trump executive order
Business

FDA fast-tracks psychedelic drug research following Trump executive order

FILE PHOTO: Psilocybin or “magic mushrooms” are seen in an undated photo provided by the U.S. Drug Enforcement Agency (DEA) in Washington, U.S. May 7, 2019. DEA | Reuters The U.S. Food and Drug Administration on Friday announced a series of measures aimed at accelerating the development of psychedelic treatments for serious mental illness. That […]

Read More
New York’s pied-a-terre tax sets up legal fight over values
Business

New York’s pied-a-terre tax sets up legal fight over values

A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. New York’s proposed tax on second homes worth more than $5 million is likely to spark costly legal battles over how to value […]

Read More